Stay updated with breaking news from Roya whitfield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nektar Therapeutics (NASDAQ:NKTR – Get Rating) Director Roy A. Whitfield sold 30,000 shares of Nektar Therapeutics stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $0.57, for a total transaction of $17,100.00. Following the sale, the director now owns 216,250 shares in the company, valued at $123,262.50. […] ....